Immune checkpoint‑targeted cancer immunotherapies
Tumor cells may express on their surface various characteristic antigens that can induce antitumor immunity. However, cancer in human body may induce an immunosuppressive microenvironment that limits immune response to its antigens. For many years scientists have tried to develop an immunotherapy wh...
Main Authors: | Julian Swatler, Ewa Kozłowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2016-01-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://www.phmd.pl/fulltxt.php?ICID=1192926 |
Similar Items
-
Immune checkpoint‑targeted cancer immunotherapies
by: Julian Swatler, et al.
Published: (2016-01-01) -
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
by: Sarabjot Pabla, et al.
Published: (2019-02-01) -
Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
by: E. V. Shubnikova, et al.
Published: (2020-03-01) -
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
by: Ernesto Rossi, et al.
Published: (2019-07-01) -
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
by: Muhammad Zubair Afzal, et al.
Published: (2018-07-01)